Michael J. Merriman
Known title: DirectorCIK: 0001211005
Associated companies
Transaction History
| RGS | ▼ Sell | Open Market | 500 | $14K | 12/17/2025 | View on chart |
| RGS | ▲ Buy | Grant | 2,727 | $0 | 11/14/2025 | View on chart |
| NDSN | ▲ Buy | Grant | 822 | $191K | 11/1/2025 | View on chart |
| RGS | ▲ Buy | Grant | 4,800 | $0 | 11/25/2024 | View on chart |
| NDSN | ▲ Buy | Grant | 747 | $186K | 11/1/2024 | View on chart |
| NDSN | ▲ Buy | Grant | 749 | $158K | 11/1/2023 | View on chart |
| NDSN | ▲ Buy | Grant | 730 | $165K | 11/1/2022 | View on chart |
| RGS | ▲ Buy | Grant | 39,855 | $0 | 11/5/2021 | View on chart |
| NDSN | ▲ Buy | Grant | 608 | $145K | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Nordson Packaging Recovery Cited Amid Valuation Concerns
Recent commentary highlights a genuine recovery in Nordson's packaging segment, though analysts note the stock price reflects this optimism. The company trades at a trailing P/E of 32.8, which some view as a premium relative to its current valuation. With the stock near its 52-week high, the market is closely watching whether operational improvements can justify the current price point.
Nordson Packaging Recovery Cited Amid Valuation Concerns. Recent commentary highlights a genuine recovery in Nordson's packaging segment, though analysts note the stock price reflects this optimism. The company trades at a trailing P/E of 32.8, which some view as a premium relative to its current valuation. With the stock near its 52-week high, the market is closely watching whether operational improvements can justify the current price point.